BUSINESS● LOW3d ago · Oct 24, 2026, 6:56 PM
Biotech stocks are surging. How investors can play the new drug innovation boom
CNBC · global
Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS11m agoThe pact that aims to return tourism's wealth to residentsEuroNews [en]BUSINESS11m agoWhy Hong Kong developer CK Asset sold a mall at an ‘exceptionally cheap’ priceSouth China Morning Post